Literature DB >> 7214790

Effect of erythromycin base on theophylline kinetics.

B J Zarowitz, S J Szefler, G M Lasezkay.   

Abstract

Because of several recent reports describing altered theophylline elimination in the presence of salts of erythromycin, the effect of a 10-day course of erythromycin base on theophylline kinetics was studied in eight healthy adult men. Theophylline (4 mg/kg) was given on four separate study days: (1) prior to starting erythromycin, (2) on the third day of erythromycin administration, (3) on the tenth day of erythromycin administration, and (4) 2 weeks after the course of erythromycin was completed. Mean theophylline kinetic parameter values on each of the 4 study days were: apparent volume of distribution (Vd), 0.466, 0.466, 0.472, and 0.470 1/kg; elimination half-life (t1/2), 7.4, 7.8, 8.5, and 7.0 hr; and total body clearance (ClB), 0.747, 0.723, 0.683, and 0.821 ml/min/kg. A maximum decrease of 20.7% in theophylline ClB was noted by the third study day. Two weeks after erythromycin was discontinued, the greatest increase in ClB observed was 45.7%. Differences in t1/2 and ClB between the third and fourth study days were statistically significant (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214790     DOI: 10.1038/clpt.1981.84

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  18 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.

Authors:  R C Dockens; D Rapoport; D Roberts; D S Greene; R H Barbhaiya
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

3.  Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium.

Authors:  T Hasegawa; K Takagi; M Nadai; Y Ogura; T Nabeshima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 4.  Theophylline.

Authors:  E F Ellis
Journal:  Clin Rev Allergy       Date:  1983-03

5.  Lack of dose dependent kinetics of theophylline.

Authors:  P J Brown; L J Dusci; G M Shenfield
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Enprofylline disposition in the presence and absence of amoxycillin or erythromycin.

Authors:  D S Sitar; F Y Aoki; D J Hoban; K G Hidinger; P R Montgomery; P A Mitenko
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

Review 7.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

8.  Spiramycin has no effect on serum theophylline in asthmatic patients.

Authors:  D Debruyne; A Jehan; M C Bigot; B Lechevalier; J N Prevost; M Moulin
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 9.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

Review 10.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.